Study type: In vivo/preclinical · Status: Verified against declared source
Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.
International journal of molecular medicine · 2017
Study scale: Not reported
Abstract only: Open source record
Product or molecular entity relationships
- Thymosin Beta-4 (TB500): Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Not reported in the reviewed source.
Methods
Not reported in the reviewed source.
Scale or participants
Not reported in the reviewed source.
Key findings
The survival of transplanted stem cells in ischemic tissue is poor.
Limitations and uncertainty
The survival of transplanted stem cells in ischemic tissue is poor.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.